Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Olympus Corporation

7733.TJPX
Healthcare
Medical - Instruments & Supplies
¥1310.50
¥-30.00(-2.24%)
Japanese Market opens in 17h 35m

Olympus Corporation Fundamental Analysis

Olympus Corporation (7733.T) shows moderate financial fundamentals with a PE ratio of 17.01, profit margin of 8.59%, and ROE of 11.34%. The company generates $987.3B in annual revenue with moderate year-over-year growth of 7.73%.

Key Strengths

Cash Position13.63%
PEG Ratio-1.34
Current Ratio1.63

Areas of Concern

No major concerns flagged.
We analyze 7733.T's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 65.6/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.

Fundamental Health Score

C+
65.6/100

We analyze 7733.T's fundamental strength across five key dimensions:

Efficiency Score

Weak

7733.T struggles to generate sufficient returns from assets.

ROA > 10%
5.82%

Valuation Score

Excellent

7733.T trades at attractive valuation levels.

PE < 25
17.01
PEG Ratio < 2
-1.34

Growth Score

Moderate

7733.T shows steady but slowing expansion.

Revenue Growth > 5%
7.73%
EPS Growth > 10%
-48.48%

Financial Health Score

Excellent

7733.T maintains a strong and stable balance sheet.

Debt/Equity < 1
0.31
Current Ratio > 1
1.63

Profitability Score

Weak

7733.T struggles to sustain strong margins.

ROE > 15%
11.34%
Net Margin ≥ 15%
8.59%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is 7733.T Expensive or Cheap?

P/E Ratio

7733.T trades at 17.01 times earnings. This indicates a fair valuation.

17.01

PEG Ratio

When adjusting for growth, 7733.T's PEG of -1.34 indicates potential undervaluation.

-1.34

Price to Book

The market values Olympus Corporation at 1.87 times its book value. This may indicate undervaluation.

1.87

EV/EBITDA

Enterprise value stands at 6.28 times EBITDA. This is generally considered low.

6.28

How Well Does 7733.T Make Money?

Net Profit Margin

For every $100 in sales, Olympus Corporation keeps $8.59 as profit after all expenses.

8.59%

Operating Margin

Core operations generate 17.87 in profit for every $100 in revenue, before interest and taxes.

17.87%

ROE

Management delivers $11.34 in profit for every $100 of shareholder equity.

11.34%

ROA

Olympus Corporation generates $5.82 in profit for every $100 in assets, demonstrating efficient asset deployment.

5.82%

Following the Money - Real Cash Generation

Operating Cash Flow

Olympus Corporation produces operating cash flow of $123.48B, showing steady but balanced cash generation.

$123.48B

Free Cash Flow

Olympus Corporation produces free cash flow of $63.98B, offering steady but limited capital for shareholder returns and expansion.

$63.98B

FCF Per Share

Each share generates $58.10 in free cash annually.

$58.10

FCF Yield

7733.T converts 4.43% of its market value into free cash.

4.43%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

17.01

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-1.34

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.87

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.46

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.31

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.63

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.11

vs 25 benchmark

ROA

Return on assets percentage

0.06

vs 25 benchmark

ROCE

Return on capital employed

0.17

vs 25 benchmark

How 7733.T Stacks Against Its Sector Peers

Metric7733.T ValueSector AveragePerformance
P/E Ratio17.0128.25 Better (Cheaper)
ROE11.34%780.00% Weak
Net Margin8.59%-20122.00% (disorted) Weak
Debt/Equity0.310.30 Neutral
Current Ratio1.634.66 Neutral
ROA5.82%-14687.00% (disorted) Weak

7733.T outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Olympus Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

43.43%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

161.57%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

63.55%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ